Project Details
| Status | Active |
|---|---|
| Effective start/end date | 3/10/20 → 2/28/25 |
Funding
- National Institute of Allergy and Infectious Diseases: $1,931,055.00
Safety and immunogenicity of a novel Rift Valley fever candidate vaccine, RVax-1
- Ikegami, Tetsuro (PI)
Project: Research project